Антираковая диета. Продукты, которые мы должны есть, чтобы защититься от опасного недуга - читать онлайн книгу. Автор: Давид Хаят cтр.№ 56

{48} Pantuck A. J., Leppert J. T., Zomorodian N., Aronson W., Hong J., Barnard R. J., Seeram N., Liker H., Wang H., Elashoff R., Heber D., Aviram M., Ignarro L., Belldegrun A., «Phase II study of pomegranate juice for men with rising prostate-specific antigen following surgery or radiation for prostate cancer», Clin. Cancer Res., 2006, 2 (13), p. 4018–4026.

{49} Gil M. I., Tomâs-Barberân F. A., Hess-Pierce B., Holcroft D. M., Kader A. A., «Antioxidant activity of pomegranate juice and its relationship with phenolic composition and processing», op. cit.

{50} MacMahon B., Yen S., Trichopoulos D., Warren K., Nardi G. «Coffee and cancer of the pancreas», N. Engl. J. Med., 1981, 304 (11), p. 630–633.

{51} Nkondjock A., «Coffee consumption and the risk of cancer: An overview», Cancer Lett., 2008, 277 (2), p. 121–125.

{52} World Cancer Research Fund, Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective, op. cit.

{53} Pelucchi C., Tavani A., La Vecchia C., «Coffee and alcohol consumption and bladder cancer», Scand. J. Urol. Nephrol., 2008, 218, suppl., p. 37–44.

{54} Baker J. A., Beehler G. P., Sawant A. C., Jayaprakash V., Mc-Cann S. E., Moysich K. B., «Consumption of coffee, but not black tea, is associated with decreased risk of premenopausal breast cancer», J. Nutr., 2006, 136 (1), p. 166–171.

{55} Nkondjock A., Ghadirian P., Kotsopoulos J., Lubinski J., Lynch H., Kim Sing C., Horsman D., Rosen B., Isaacs C., Weber B., Foulkes W., Ainsworth P., Tung N., Eisen A., Friedman E., Eng C., Sun P., Narod S. A., «Coffee consumption and breast cancer risk among BRCA1 and BRCA2 mutation carriers», Int. J. Cancer, 2006, 118 (1), p. 103–107.

{56} Shanafelt T. D., Lee Y. K., Call T. G., Nowakowski G. S., Dingli D., Zent C. S., Kay N. E., «Clinical effects of oral green tea extracts in four patients with low grade B-cell malignancies», Leuk. Res., 2006, 30 (6), p. 707–712.

{57} Tsao A. S., Liu D., Martin J., Tang X. M., Lee J. J., El-Naggar A. K., Wistuba I., Culotta K. S., Mao L., Gillenwater A., Sagesaka Y. M., Hong W. K., Papadimitrakopoulou V., «Phase II randomized, placebo-controlled trial of green tea extract in patients with high-risk oral premalignant lesions», Cancer Prev. Res. (Phila Pa), 2009, 2 (11), p. 931–941.

{58} Tsao A. S., Liu D., Martin J., Tang X. M., Lee J. J., El-Naggar A. K., Wistuba I., Culotta K. S., Mao L., Gillenwater A., Sagesaka Y. M., Hong W. K., Papadimitrakopoulou V., «Phase II randomized, placebo-controlled trial of green tea extract in patients with high-risk oral premalignant lesions», op. cit.

{59} World Cancer Research Fund, Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective, op. cit.

Глава 10

Бады и нутриенты. Полезны или вредны?

{1} Vidal, Le Guide Vidal des compléments alimentaires disponible en librairie, Communiqué de Presse, 2010. Disponible sur: http://www. vidal.fr/presse/espace-grand-public/363-guide-complements-alimentaires (consulté le 15 mars 2010).

{2} AFSSA, Etude individuelle nationale des consommations alimentaires 2 (INCA 2) 2006–2007, 2009. Disponible sur: http://www.afssa.fr/ Documents/PASER-Ra-INCA2.pdf (consulté le 15 mars 2010).

{3} Ferrucci L. M., McCorkle R., Smith T., Stein K. D., Cartmel B., «Factors related to the use of dietary supplements by cancer survivors», J. Altern. Complement. Med., 2009, 15 (6), p. 673–680.

{4} Cassileth B. R., Heitzer M., Wesa K., «The public health impact of herbs and nutritional supplements», Pharm. Biol., 2009, 47 (8), p. 761–767.

{5} Kimura Y., Ito H., Ohnishi R., Hatano T., «Inhibitory effects of polyphenols on human cytochrome P450 3A4 and 2C9 activity», Food Chem. Toxicol., 2009, 48 (1), p. 429–435.

{6} Goodman G. E., Thornquist M. D., Balmes J., Cullen M. R., Meyskens F. L. Jr, Omenn G. S., Valanis B., Williams J. H. Jr., «The beta-carotene and retinol efficacy trial: Incidence of lung cancer and cardiovascular disease mortality during 6-year follow-up after stopping beta-carotene and retinol supplements», J. Natl. Cancer Inst., 2004, 96 (23), p. 1743–1750.

{7} Virtamo J., Pietinen P., Huttunen J. K., Korhonen P., Malila N., Virtanen M. J., Albanes D., Taylor P. R., Albert P., ATBC Study Group, «Incidence of cancer and mortality following alpha-tocopherol and beta-carotene supplementation: A postintervention follow-up», JAMA, 2003, 290 (4), p. 476–485.

{8} Cook N. R., Le I. M., Manson J. E., Buring J. E., Hennekens C. H., «Effects of beta-carotene supplementation on cancer Incidence by baseline characteristics in the Physicians’ Health Study (United States)», Cancer Causes Control, 2000, 11 (7), p. 617–626.

{9} Lee I. M., Cook N. R., Manson J. E., Buring J. E., Hennekens C. H., «Beta-carotene supplementation and Incidence of cancer and cardiovascular disease: The Women’s Health Study», J. Natl. Cancer Inst., 1999, 91 (24), p. 2102–2106.

{10} De Klerk N. H., Musk A. W., Ambrosini G. L., Eccles J. L., Hansen J., Olsen N., Watts V. L., Lund H. G., Pang S. C., Beilby J., Hobbs M. S., «Western perth asbestos workers, Vitamin A and cancer prevention II: comparison of the effects of retinol and beta-carotene», Int. J. Cancer, 1998, 75 (3), p. 362–367.

{11} Hercberg S., Kesse-Guyot E., Druesne-Pecollo N., Touvier M., Favier A., Latino-Martel P., Briançon S., Galan P., «Incidence of cancers, ischemic cardiovascular diseases and mortality during 5-year follow-up after stopping antioxidant vitamins and minerals supplements: A postintervention follow-up in the SU.VI.MAX Study», Int. J. Cancer, 2010, epub.

{12} Meyer F., Galan P., Douville P., Bairati I., Kegle P., Bertrais S., Estaquio C., Hercberg S., «Antioxidant vitamin and mineral supplementation and prostate cancer prevention in the SU.VI.MAX trial», Int. J. Cancer, 2005, 116 (2), p. 182–186.

{13} Hercberg S., Ezzedine K., Guinot C. et al., «Antioxidant supplementation increases the risk of skin cancers in women but not in men», J. Nutr., 2007, 137, p. 2098–2105.

{14} Omenn G. S., Goodman G. E., Thornquist M. D., Balmes J., Cullen M. R., Glass A., Keogh J. P., Meyskens F. L. Jr, Valanis B., Williams J. H. Jr, Barnhart S., Cherniack M. G., Brodkin C. A., Hammar S., «Risk factors for lung cancer and for intervention effects in CARET, the beta-carotene and retinol efficacy trial», J. Natl. Cancer Inst, 1996, 88 (21), p. 1550–1559.

{15} National Cancer Institute, Selenium and Vitamin E Cancer Prevention Trial (SELECT), 2008. Disponible sur: http://www.cancer.gov/ newscenter/pressreleases/SELECTQandA (consulté le 15 mars 2010).

{16} Nelson R. L., «Iron and colorectal cancer risk, human studies», Nutr. Rev., 2001, 59, p. 140–148.